08 Jun 2020 --- Adding two human milk oligosaccharides (HMOs) to Nestlé Health Science (NHSc)’s infant formula Althéra can reduce respiratory tract infections in infants with cow’s milk protein allergy (CMPA). This is according to the latest findings from the nutrition giant’s CINNAMON study, which were presented at the digital European Academy of Allergy and Clinical Immunology (EAACI) annual congress. Amid a surge in concerns for breathing difficulties during the ongoing global pandemic, this research update contributes to the ever-growing research on the benefits of HMOs for early nutrition.
